Alternative splicing of mRNA is an important mechanism for organisms to enhance protein diversity from a limited number of genes. In this report, we described a novel exon insertion in the interleukin 23 (IL-23) receptor between exons 9 and 10, denoted as exon 9a. This 162 base-pair insertion was the only insertion variant discovered in more than 20 IL23R deletion variants found in the mRNA of mitogen-stimulated peripheral blood mononuclear cells (PBMC). Sequence analysis revealed that a pair of GT/AG splice donor-acceptor site and several putative cis-acting sequences were present; the insertion was identified throughout the genome and found to contain homology to the L1 retrotransposon protein. This report describes an insertion in the IL-23 receptor and due to consequent early termination within the intracellular region, causing a possible nonresponsive receptor isoform. Genes and Immunity (2008) 1-3 Mature IL-23 comprises two subunits, p19 and p40 (identical to the IL-12 p40 subunit), where the p19 subunit binds to IL-23Ra and the p40 subunit binds to IL-12Rb1.
The proinflammatory cytokine interleukin 23 (IL-23) signals through a receptor complex comprising the interleukin 12 receptor b1 (IL-12Rb1) and the interleukin 23 receptor a chain (IL-23Ra). [1] [2] [3] Mature IL-23 comprises two subunits, p19 and p40 (identical to the IL-12 p40 subunit), where the p19 subunit binds to IL-23Ra and the p40 subunit binds to IL-12Rb1. 4, 5 The IL-23 receptor complex has been observed to be selectively expressed on the so-called 'Th17' subset of CD4 þ T lymphocytes. 6 The function of IL-23 has not been clearly defined, although it has been reported to work in tandem with interleukin 6 (IL-6) and interleukin 21 (IL-21) for the proliferation and functional development of CD4 þ Th17 cells. [7] [8] [9] During the development of these cells, the lineage-associated transcription factor RORgT is upregulated. RORgT is then responsible for inducing the transcription of IL-23R, with its subsequent expression on the surface of Th17 cells. 6 Binding of IL-23 to its receptor activates STAT3 and IL-17 production is then induced. [10] [11] [12] [13] Recently, a small number of IL23R splice variants were identified in normal lymphoid cell lines and human tumor cells.
14 This study was recently independently confirmed (Kan et al., personal communication) and together these recent publications describe exon deletion splice variants of the human IL-23 receptor complex. In this report we demonstrate the presence of a novel exon insertion in that part of the mRNA encoding the intracellular region of the IL-23Ra, whose translation would lead to a C-terminally truncated protein.
Additionally, we further support the occurrence of this exon insertion by demonstrating its presence at low level in the mRNA of mitogen-stimulated peripheral blood mononuclear cells (PBMC) from healthy adult volunteers.
We prepared total RNA from the PBMC of four healthy adult volunteer donors, stimulated with either 5 mg ml À1 concanavalin A, 0.2 mg ml À1 lipopolysaccharide, 5 mg ml À1 phytohemagglutin, 20 ng ml À1 phorbol myristate acetate plus 1 mM Ionomycin, and 1 mg ml À1 of polyinosinicpolycytidylic acid double-stranded RNA. The RNA was reverse transcribed and then the cDNA was subjected to PCR using primers (P5 & P6) as previously described. 14 These primers cover the region between exon 4 to exon 11, which encodes the major part of the human IL-23Ra chain protein (Figure 1a) . Following PCR, products were cloned directly into TOPO-TA pCR2.1 (Invitrogen, Carlsbad, CA, USA), for further screening and characterization.
The wild-type (that is, non-variant; for example, NM_144701) IL23R P5/P6 fragment contains two EcoRI recognition sites (Figure 1a) . Thus, when EcoRI is used to release the PCR product insert from the cloning vector, three fragments of the insert are visible: 403 bp (exon 4-7), 155 bp (exon 7-8) and 343 bp (exons 8-11; Figure 1a ). Among the many variants present, one transcript generated from the phorbol myristate acetate and Ionomycin-stimulated PBMC demonstrated a novel digestion pattern that was incompatible with solely exon deletion variation. This transcript yielded fragments of 505, 332, 155 bp, respectively (Figure 1b ) suggesting that more than one possible alternative splicing event might have occurred in the transcript: a deletion within the exon 4-7 region and an insertion in the exon 8-11 region.
Sequence analysis of the cloned variant IL23R transcript revealed that a compound splicing event had occurred within this amplicon: a previously observed (Kan et al., personal communication) partial deletion of exon 5 (the first 71 nucleotides), together with a novel 162 nucleotide insertion between exons 9 and 10 ( Figure 1c ). The alignment of the insertion against the IL23R gene showed its location to be within intron 9; 5.5 kb downstream of exon 9. A GT/AG splice donoracceptor site, required for the pre-mRNA processing, 15, 16 was discovered on both sides of this 162 bp insertion. In addition, cis-acting sequences (a polypyrimidine tract and a possible branch point sequence (CATCGAT)) are located upstream of the AG splice acceptor site; these are important and conserved in the splicing acceptor area for correct binding and recognition of splicesome subunits [17] [18] [19] [20] [21] [22] ( Figures 2a and b) . Importantly, these suggest that this 162 bp insertion is likely to be a legitimate cryptic exon when alternative splicing occurs. For nomenclature purposes, we termed this cryptic exon 'exon 9a. ' Although, this 162 bp exon is likely to be introduced as an in-frame insertion, a TGA stop codon was identified after the translation of 10 amino acids, causing an early termination of the IL-23Ra chain protein. This early termination would result in a truncated intracellular domain of the IL-23Ra. The truncated intracellular domain does not extend to the usual three signaling tyrosine residues in the phosphorylation motif boxes. Similar to the other splice variant, containing a 67 bp partial deletion in the exon 11 of the IL23R, was also found to show a putative intracellular region missing two of the three signaling tyrosine residues.
14 Thus, binding of IL-23 to an IL-23R complex, containing these truncated isoforms, may cease the initiation of the downstream signal transduction. Hence, the 162 bp insertion, causing a truncated IL-23R, suggests a possible non-responsive receptor isoform in the IL-23 signaling.
To determine if the exon 9a insertion is found in previous donors stimulated with various mitogens, a primer set spanning the exon 9-9a and exon 10-9a junctions, were used to amplify the cDNA obtained from all donors with different stimuli for the nested PCR and real time-PCR. The real time-PCR assay showed a detection limit of 1 fg of plasmid containing exon 9a. In Figure 2c , a band of the expected size (162 bp) and of modest intensity was seen in all samples tested, following nested PCR amplification. The low expression of exon 9a suggests it is an isoform resulting from a rare alternative splicing of the pre-mRNA. Similar results were obtained from the real-time PCR showing the existence of the exon 9a variant in low, but detectable levels. Relative amounts of exon 9a were 0.003 (concanavalin A), 0.055 (lipopolysaccharide), 0.005 (phytohemagglutin), 0.036 (phorbol myristate acetate plus Ionomycin), and 0.009 (polyinosinic-polycytidylic acid) of Glyceraldehyde 3-phosphate dehydrogenase, respectively. Therefore, both amplification methods demonstrated the scarce existence of exon 9a in the individual cDNA of stimulated leukocytes.
To understand the possible biological function of this exon 9a insertion within the IL23R gene, a genome-wide 'BLAT' 23 search was carried out to determine if this insertion exists elsewhere in the human genome. The results from this search yielded approximately 200 sequences with more than 90% homology. Interestingly, in most cases these homologous sequences, located on multiple chromosomes (that is: chromosomes 1, 6, 8, 10, 22, X, etc.), also contained the entire set of splicesome binding sites including the AG/GT donor-acceptor sites, polypyrimidine tract and a branch site. Accordingly, a 'BLASTx' 24 search was carried out using the 162 bp insertion sequence; the results revealed a 94% identity to a homologous reverse transcriptase human retrotransposon L1 protein (AAB60345). 25 L1 elements are autonomous non-long terminal repeat retrotransposons, that is, long interspersed nuclear elements, which have all the necessary machinery needed to insert themselves into random locations throughout the human genome. 26, 27 Moreover, encoded in the insertion sequence are multiple stop codons, in all three reading frames, which suggests that the insertion is acting as a dominant cryptic exon carrying a termination message to halt protein translation. Therefore, in some cases, for example, environmental stress, mitogen stimulation, we speculate that the IL23R may utilize this cryptic exon by alternative splicing to generate a different isoform of the IL-23R producing a shortened intracellular region to cease downstream signaling. Thus, the location in the genome in which the transposon is inserted increases the diversity of the translated protein isoforms.
In conclusion, we describe here a novel, in-frame, insertional variant within the human IL23R mRNA (exon 9a) between exons 9 and 10. The discovery of such insertions containing high homology throughout the human genome suggests that the insertion may include an array of exon information, including splice signaling for pre-mRNA processing, which could act as a transposon shuttling itself within the genome to deliver an early termination message for translation. Additionally, the presence of the exon 9a insertion appears to be present in small amounts in the cDNA of most mitogenstimulated PBMC. This is the first description of an insertional variant of either the a or b domain of the human IL-23R complex.
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